• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者在一般实践人群中的慢性阻塞性肺疾病加重的自然史。
Am J Respir Crit Care Med. 2018 Aug 15;198(4):464-471. doi: 10.1164/rccm.201710-2029OC.
2
The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.抑郁症状与 COPD 患者急性加重率的相关性:ECLIPSE 队列 3 年纵向随访研究结果。
J Am Med Dir Assoc. 2017 Nov 1;18(11):955-959.e6. doi: 10.1016/j.jamda.2017.05.024. Epub 2017 Jul 18.
3
Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort.预测 COPD 患者再加重时间和深入了解慢性阻塞性肺疾病急性加重持续时间长的原因:一项 ECLIPSE 队列研究。
Int J Chron Obstruct Pulmon Dis. 2021 Feb 5;16:225-244. doi: 10.2147/COPD.S279315. eCollection 2021.
4
Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013.2005 年至 2013 年期间英国 COPD 患者中中重度恶化的趋势。
Respir Med. 2018 Nov;144:1-6. doi: 10.1016/j.rmed.2018.09.010. Epub 2018 Sep 17.
5
Burden of Exacerbations in Patients with Moderate to Very Severe COPD in the Netherlands: A Real-life Study.荷兰中重度慢性阻塞性肺疾病患者急性加重的负担:一项真实生活研究
COPD. 2015 Apr;12(2):132-43. doi: 10.3109/15412555.2014.898053. Epub 2014 Jun 24.
6
Chronotropic Index and Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Secondary Analysis of BLOCK COPD.变时指数与慢性阻塞性肺疾病急性加重:BLOCK COPD研究的二次分析
Ann Am Thorac Soc. 2021 Nov;18(11):1795-1802. doi: 10.1513/AnnalsATS.202008-1085OC.
7
Acute exacerbations of COPD in subjects completing pulmonary rehabilitation.完成肺康复的慢性阻塞性肺疾病(COPD)患者的急性加重期
Chest. 2007 Jul;132(1):127-34. doi: 10.1378/chest.07-0269. Epub 2007 May 2.
8
Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study.COPD 加重的频率和严重程度与未来加重和死亡风险的关系:一项英国常规医疗保健数据研究。
Int J Chron Obstruct Pulmon Dis. 2022 Mar 3;17:427-437. doi: 10.2147/COPD.S346591. eCollection 2022.
9
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.慢性阻塞性肺疾病恶化和心脏事件。SUMMIT 随机临床试验的事后队列分析。
Am J Respir Crit Care Med. 2018 Jul 1;198(1):51-57. doi: 10.1164/rccm.201711-2239OC.
10
Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.初诊时血嗜酸性粒细胞计数与慢性阻塞性肺疾病患者年度加重频率和严重程度的相关性:一项前瞻性纵向分析。
Can Respir J. 2023 Apr 26;2023:8678702. doi: 10.1155/2023/8678702. eCollection 2023.

引用本文的文献

1
Predictors of mortality and hospitalised exacerbations in obstructive airway diseases.阻塞性气道疾病死亡率及住院加重的预测因素
ERJ Open Res. 2025 Sep 8;11(5). doi: 10.1183/23120541.01276-2024. eCollection 2025 Sep.
2
Prevalence and Risk Factors of Arrhythmias in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.慢性阻塞性肺疾病急性加重患者心律失常的患病率及危险因素:一项系统评价和荟萃分析
Int J Chron Obstruct Pulmon Dis. 2025 Sep 3;20:3059-3072. doi: 10.2147/COPD.S545658. eCollection 2025.
3
Establishment and validation of a nomogram for predicting acute exacerbation of chronic obstructive pulmonary disease based on the C-reactive protein-triglyceride-glucose index.基于C反应蛋白-甘油三酯-葡萄糖指数的慢性阻塞性肺疾病急性加重预测列线图的建立与验证
Medicine (Baltimore). 2025 Sep 5;104(36):e42754. doi: 10.1097/MD.0000000000042754.
4
Patient Perceptions on the Role of Informal Caregiver Support in Managing Advanced COPD.患者对非正式照护者支持在晚期慢性阻塞性肺疾病管理中作用的认知
J Patient Exp. 2025 Jul 23;12:23743735251341727. doi: 10.1177/23743735251341727. eCollection 2025.
5
Streamlining referrals by establishing a UAE-specific referral algorithm for CVD patients with overlapping COPD: a collaborative effort by cardiologists and pulmonologists.通过为患有重叠慢性阻塞性肺疾病(COPD)的心血管疾病(CVD)患者建立特定于阿联酋的转诊算法来简化转诊流程:心脏病专家和肺病专家的合作成果。
Front Cardiovasc Med. 2025 Jun 24;12:1531966. doi: 10.3389/fcvm.2025.1531966. eCollection 2025.
6
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.慢性阻塞性肺疾病与英国心肺风险的管理:一项系统文献综述及改良德尔菲研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025.
7
Risk of exacerbations, hospitalisation, and mortality in adults with physician-diagnosed chronic obstructive pulmonary disease with normal spirometry and adults with preserved ratio impaired spirometry in Sweden: retrospective analysis of data from a nationwide cohort study.瑞典肺功能正常的医生诊断为慢性阻塞性肺疾病的成年人以及肺功能比值受损但保留的成年人的急性加重、住院和死亡风险:一项全国性队列研究数据的回顾性分析
Lancet Reg Health Eur. 2025 May 14;54:101322. doi: 10.1016/j.lanepe.2025.101322. eCollection 2025 Jul.
8
Patterns of care in the management of high-risk COPD in Australia (2015-2019): an observational study for the CONQUEST quality improvement program.澳大利亚高危慢性阻塞性肺疾病管理中的护理模式(2015 - 2019年):一项针对征服质量改进项目的观察性研究
Lancet Reg Health West Pac. 2025 May 6;58:101555. doi: 10.1016/j.lanwpc.2025.101555. eCollection 2025 May.
9
Eosinophils in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的嗜酸性粒细胞
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251335800. doi: 10.1177/17534666251335800. Epub 2025 May 28.
10
Frequency of Stroke in Patients With Chronic Obstructive Pulmonary Disease: A Retrospective Study.慢性阻塞性肺疾病患者中风的发生率:一项回顾性研究。
Cureus. 2025 Apr 26;17(4):e83054. doi: 10.7759/cureus.83054. eCollection 2025 Apr.

本文引用的文献

1
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.慢性阻塞性肺疾病患者的加重频率:SPIROMICS 队列分析。
Lancet Respir Med. 2017 Aug;5(8):619-626. doi: 10.1016/S2213-2600(17)30207-2. Epub 2017 Jun 28.
2
Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care.在英国初级医疗保健中,用于诊断慢性阻塞性肺疾病的肺量计记录的有效性及解读
Int J Chron Obstruct Pulmon Dis. 2017 Jun 7;12:1663-1668. doi: 10.2147/COPD.S133891. eCollection 2017.
3
Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records.英国电子医疗记录中慢性阻塞性肺疾病急性加重住院情况的记录。
Clin Epidemiol. 2016 Nov 21;8:771-782. doi: 10.2147/CLEP.S117867. eCollection 2016.
4
Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records.英国初级医疗电子健康记录中慢性阻塞性肺疾病急性加重记录的验证
PLoS One. 2016 Mar 9;11(3):e0151357. doi: 10.1371/journal.pone.0151357. eCollection 2016.
5
The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study.COPD 急性加重后,加重频率对死亡率的影响:基于登记的队列研究。
BMJ Open. 2014 Dec 19;4(12):e006720. doi: 10.1136/bmjopen-2014-006720.
6
Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study.基层医疗人群中慢性阻塞性肺疾病急性加重的危险因素:一项回顾性观察队列研究。
BMJ Open. 2014 Dec 18;4(12):e006171. doi: 10.1136/bmjopen-2014-006171.
7
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort.慢性阻塞性肺疾病(COPD)的住院加重:ECLIPSE队列中的危险因素及预后
Chest. 2015 Apr;147(4):999-1007. doi: 10.1378/chest.14-0655.
8
Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD).慢性阻塞性肺疾病记录在临床实践研究数据链(CPRD-GOLD)中的验证。
BMJ Open. 2014 Jul 23;4(7):e005540. doi: 10.1136/bmjopen-2014-005540.
9
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.慢性阻塞性肺疾病频繁加重表型的机制和影响。
BMC Med. 2013 Aug 14;11:181. doi: 10.1186/1741-7015-11-181.
10
Exacerbation frequency and course of COPD.COPD 的加重频率和过程。
Int J Chron Obstruct Pulmon Dis. 2012;7:653-61. doi: 10.2147/COPD.S34186. Epub 2012 Sep 21.

慢性阻塞性肺疾病患者在一般实践人群中的慢性阻塞性肺疾病加重的自然史。

Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease.

机构信息

1 Respiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College London, London, United Kingdom.

2 Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom; and.

出版信息

Am J Respir Crit Care Med. 2018 Aug 15;198(4):464-471. doi: 10.1164/rccm.201710-2029OC.

DOI:10.1164/rccm.201710-2029OC
PMID:29474094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6118021/
Abstract

RATIONALE

Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) are important adverse events in the natural history of chronic obstructive pulmonary disease (COPD).

OBJECTIVES

To investigate the natural history of AECOPDs over 10 years of follow-up.

METHODS

We identified 99,574 patients with COPD from January 1, 2004, to March 31, 2015, from the UK Clinical Practice Research Datalink. We defined moderate AECOPDs as those managed outside hospital and severe as those requiring hospitalization. During the baseline period (first year of follow-up), patients were grouped according to the number and severity of AECOPDs and then followed for a maximum of 10 years (mean, 4.9 yr). We investigated the effect of baseline AECOPD number and severity on risk of further events and death.

MEASUREMENTS AND MAIN RESULTS

Around one-quarter of the patients with COPD did not exacerbate during follow-up. Compared with no AECOPDs in the baseline period, AECOPD number predicted the future long-term rate of AECOPDs in a graduated fashion, ranging from hazard ratio (HR) of 1.71 (1.66-1.77) for one event to HR of 3.41 (3.27-3.56) for five or more events. Two or more moderate AECOPDs were also associated with an increased risk of death in a graduated fashion, ranging from HR of 1.10 (1.03-1.18) for two moderate AECOPDs to HR of 1.57 (1.45-1.70) for five or more moderate AECOPDs, compared with those with no AECOPDs at baseline. Severe AECOPDs were associated with an even higher risk of death (HR, 1.79; 1.65-1.94).

CONCLUSIONS

A large proportion of patients with COPD do not exacerbate over a maximum 10 years of follow-up. AECOPD frequency in a single year predicts long-term AECOPD rate. Increasing frequency and severity of AECOPDs is associated with risk of death and highlights the importance of preventing AECOPDs.

摘要

背景

慢性阻塞性肺疾病(COPD)的急性加重(AECOPD)是 COPD 自然病程中的重要不良事件。

目的

研究 AECOPD 在 10 年随访期间的自然病程。

方法

我们从 2004 年 1 月 1 日至 2015 年 3 月 31 日,从英国临床实践研究数据链接中确定了 99574 例 COPD 患者。我们将中度 AECOPD 定义为在院外管理的 AECOPD,重度 AECOPD 定义为需要住院的 AECOPD。在基线期(随访的第一年),根据 AECOPD 的数量和严重程度将患者分组,然后随访最长 10 年(平均随访时间为 4.9 年)。我们研究了基线期 AECOPD 数量和严重程度对未来事件和死亡风险的影响。

测量和主要结果

大约四分之一的 COPD 患者在随访期间没有加重。与基线期无 AECOPD 相比,AECOPD 数量呈梯度式预测未来长期 AECOPD 发病风险,从 1 次 AECOPD 的风险比(HR)1.71(1.66-1.77)到 5 次或以上 AECOPD 的 HR 3.41(3.27-3.56)。2 次或更多次中度 AECOPD 也呈梯度式与死亡风险增加相关,从 2 次中度 AECOPD 的 HR 1.10(1.03-1.18)到 5 次或更多次中度 AECOPD 的 HR 1.57(1.45-1.70),与基线期无 AECOPD 患者相比。重度 AECOPD 与更高的死亡风险相关(HR 1.79;1.65-1.94)。

结论

很大一部分 COPD 患者在最长 10 年的随访期间没有加重。单一年度的 AECOPD 频率可预测长期 AECOPD 发生率。AECOPD 发生频率和严重程度的增加与死亡风险相关,突出了预防 AECOPD 的重要性。